Filter
1886
Filtered Results: 1886
Text search:
Food
and
Drug
Administration
Featured
Recommendations
199
New Publications
557
Language
Document type
No document type
1113
Guidelines
329
Studies & Reports
233
Manuals
91
Strategic & Response Plan
55
Fact sheets
26
Training Material
21
Situation Updates
8
Resource Platforms
3
Infographics
3
Brochures
2
Videos
2
Countries / Regions
India
112
Ethiopia
73
Kenya
67
Nigeria
56
Global
52
Tanzania
49
South Africa
46
Uganda
40
Ghana
38
Liberia
37
Myanmar / Burma
35
Western and Central Europe
34
Sierra Leone
32
Nepal
30
Rwanda
30
Philippines
29
Zambia
29
Bangladesh
23
Latin America and the Carribbean
22
Africa
19
Malawi
18
Eastern Europe
17
Indonesia
15
Namibia
14
USA
13
Lesotho
13
Zimbabwe
12
Russia
12
Cambodia
11
Colombia
11
South Sudan
10
Congo, Democratic Republic of
9
Germany
8
Botswana
8
Syria
7
Eswatini/ Swaziland
7
Brazil
7
Ukraine
7
West and Central Africa
7
Middle East and North Africa
7
South–East Asia Region
7
Mozambique
6
Cameroon
5
Haiti
5
Thailand
5
Sudan
5
Eastern Europe and Central Asia
5
Jordan
4
East and Southern Africa
4
Venezuela
4
Laos
4
Somalia
3
Pakistan
3
Iraq
3
Papua New Guinea
3
Argentina
3
Peru
3
Western Pacific Region
3
Paraguay
3
Asia
3
Tajikistan
3
Iran
3
Senegal
2
Morocco
2
Turkey
2
Benin
2
Central African Republic
2
Libya
2
Angola
2
Sri Lanka
2
Yemen
2
Poland
2
Timor Leste/ East Timor
2
Vietnam
2
United Kingdom
2
Guinea
1
Burkina Faso
1
Mali
1
Guinea-Bissau
1
Saudi Arabia
1
Afghanistan
1
Lebanon
1
China
1
Singapore
1
Switzerland
1
Hungary
1
El Salvador
1
Greece
1
Mexico
1
Chile
1
Bhutan
1
Palestine
1
Albania
1
Qatar
1
Lithuania
1
Moldova
1
Georgia
1
North America
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
829
Clinical Guidelines
208
Public Health
85
Women & Child Health
77
Key Resources
46
Pharmacy & Technologies
26
Capacity Building
25
Toolboxes
AMR
139
Mental Health
129
TB
129
COVID-19
124
HIV
118
Pharmacy
90
NTDs
49
Rapid Response
48
Caregiver
44
Ebola
37
NCDs
34
Planetary Health
29
Refugee
26
Conflict
17
Specific Hazards
14
Global Health Education
14
Disability
13
Cholera
10
Natural Hazards
9
Zika
9
Polio
6
Social Ethics
4
Health Financing Toolbox
3
Health Financing
1
This executive summary contains all the new recommendations that will be incorporated into the fifth edition of the Medical eligibility criteria (MEC) for contraceptive use. In addition to the recommendations themselves, the summary provides an introduction to the guideline, a description of the met...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been support...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing docum...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate ...
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly ... outlines key actions and measures that the blood services should take to mitigate the potential risk to the safety and sufficiency of the blood supplies during the pandemic.
It should be read in conjunction with WHO Guidance for National Blood Services on Protecting the Blood Supply During Infectious Disease Outbreaks, which provides general guidance on the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply.
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware ... software packages listed in the following specifications are described in detail in order to serve also other pathologies and conditions, like trauma and pneumonia.
Through the definition of "minimum technical requirements", this document is recommended to support decision-making regarding the selection, incorporation, allocation and use of portable X-ray systems and is intended for health care providers, managers of imaging departments, procurement and regulatory agencies, policymakers and planning officers in ministries of health, as well as biomedical engineering professionals, medical physicists, the private health sector, medical device industry and intergovernmental and international agencies.
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newbor...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease ... death; (iii) how virulent the variant is compared to other variants; and (iv) how populations understand these dynamics, perceive risk and follow control measures, including public health and social measures (PHSM).
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety ... efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S). PIC/S aims to develop international standards between countries and pharmaceutical inspection
authorities, to provide harmonised and constructive co-operation in the field of GMP. PIC/S affiliation is subject to initial and periodic assessment of the participating authority to ensure that it has equivalent legislation, regulatory and enforcement procedures and inspection capacity.
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and ...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increa...
Today’s children, and their children, are the ones who will live with the consequences of climate change.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop...
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publ...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resista...
Managing epidemics
recommended
Key facts about major deadly diseases.This manual provides concise and up-to-date knowledge on 15 infectious diseases that have the potential to become international threats, and tips on how to resp...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit pr...
The toolkit pr...
This Guideline, the first for the country, draws from national health sector reforms and integration agenda as outlined in the key national strategic documents. The Guide applies lessons learnt from the SRH/HIV Linkages project ... its scale-up; other national experiences and from regional and global evidence and guidance on high-impact interventions that promote sustainable, equitable and effective delivery of health services to achieve Universal Health coverage.
